U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07902583) titled 'Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55' on Oct. 22.
Brief Summary: The purpose of this Phase I trial is to determine the breadth of immune response elicited by vaccination against betacoronaviruses and assess the safety, reactogenicity, and immunogenicity of Cov-RBD-scNP-001 with or without ACU-026-001-1 adjuvant in healthy adults ages 18-55.
Study Start Date: Nov. 16
Study Type: INTERVENTIONAL
Condition:
Coronavirus Infection
Intervention:
BIOLOGICAL: Cov-RBD-scNP-001
All subjects in this group will receive the investigational vaccine Cov-RBD-scNP-001
BIOLOGICAL: ACU-026-001-1
All subjects in this group ...